$2.31
-0.06 (-2.53%)
Open$2.37
Previous Close$2.37
Day High$2.39
Day Low$2.30
52W High$5.59
52W Low$2.94
Volume—
Avg Volume91.9K
Market Cap287.34M
P/E Ratio—
EPS$-0.52
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,580.1% upside
Current
$2.31
$2.31
Target
$38.81
$38.81
$30.55
$38.81 avg
$50.01
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 887.55M | 748.92M | 117.29M |
| Net Income | -75,824,640 | -57,583,474 | 15.94M |
| Profit Margin | -8.5% | -8.1% | 13.6% |
| EBITDA | 6.05M | 4.85M | 20.19M |
| Free Cash Flow | — | — | 10.06M |
| Rev Growth | +18.5% | +18.5% | +17.8% |
| Debt/Equity | 1.25 | 1.25 | 1.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |